Approval · Notice of Compliance 590 · 2002
VAQTA: Notice of Compliance 590
Issued January 10, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 590
- Date
- January 10, 2002
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Active immunizing agent against hepatitis A virus
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VAQTA | 02229702 | Marketed |
Medicinal ingredients
- HEPATITIS A VACCINE, INACTIVATED 50 UNIT per ML